Collaborations Pharmaceuticals, Inc. is a company that provides Chagas disease, Peroxisome proliferator-activated receptor, Severe acute respiratory syndrome and more. Collaborations Pharmaceuticals, Inc. is headquartered in United States North Carolina. Collaborations Pharmaceuticals, Inc. was founded in 2015. Collaborations Pharmaceuticals, Inc. has a total of 14 patents and 16 literature
What kind of company is Collaborations Pharmaceuticals, Inc.?
Collaborations Pharmaceuticals, Inc. is an American private company that engages in drug discovery for rare and neglected diseases and platform for generative...
What is Collaborations Pharmaceuticals, Inc.'s official website?